These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1914362)

  • 21. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.
    Cooley TP; Kunches LM; Saunders CA; Ritter JK; Perkins CJ; McLaren C; McCaffrey RP; Liebman HA
    N Engl J Med; 1990 May; 322(19):1340-5. PubMed ID: 2139174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.
    Knupp CA; Brater DC; Relue J; Barbhaiya RH
    J Clin Pharmacol; 1993 Oct; 33(10):912-7. PubMed ID: 8227460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads.
    Damle BD; Yan JH; Behr D; O'Mara E; Nichola P; Kaul S; Knupp C
    J Clin Pharmacol; 2002 Apr; 42(4):419-27. PubMed ID: 11936567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ranitidine (antacid), food, and formulation on the pharmacokinetics of fostamatinib: results from five phase I clinical studies.
    Flanagan T; Martin P; Gillen M; Mathews D; Lisbon E; Kruusmägi M
    Eur J Clin Pharmacol; 2017 Feb; 73(2):185-195. PubMed ID: 27858108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.
    Wang Y; Livingston E; Patil S; McKinney RE; Bardeguez AD; Gandia J; O'Sullivan MJ; Clax P; Huang S; Unadkat JD
    J Infect Dis; 1999 Nov; 180(5):1536-41. PubMed ID: 10515813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids.
    Carpen ME; Poplack DG; Pizzo PA; Balis FM
    J Chromatogr; 1990 Mar; 526(1):69-75. PubMed ID: 2111332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat.
    Ray GF; Mason WD; Badr MZ
    Drug Metab Dispos; 1990; 18(5):654-8. PubMed ID: 1981715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of absorption of didanosine after rectal administration in human immunodeficiency virus-infected patients.
    Wintergerst U; Rolinski B; Sölder B; Bogner JR; Wolf E; Jäger H; Roscher AA; Belohradsky BH
    Antimicrob Agents Chemother; 1999 Mar; 43(3):699-701. PubMed ID: 10049294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnitude and duration of elevated gastric pH in patients infected with human immunodeficiency virus after administration of chewable, dispersible, buffered didanosine tablets.
    DePestel DD; Kazanjian PH; Cinti SK; Kauffman CA; Carver PL
    Pharmacotherapy; 2004 Nov; 24(11):1539-45. PubMed ID: 15537559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonlinear disposition of intravenous 2',3'-dideoxyinosine in rats.
    Wientjes MG; Mukherji E; Au JL
    Pharm Res; 1992 Aug; 9(8):1070-5. PubMed ID: 1409380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drug therapy for patients with HIV. Nursing implications in the administration of 2',3'-dideoxyinosine (ddI).
    Shay LE; Thomas RV; Wyvill KM; Adamo DO; Jenkins JF
    Cancer Nurs; 1990 Oct; 13(5):269-77. PubMed ID: 2123127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team.
    Stevens RC; Rodman JH; Yong FH; Carey V; Knupp CA; Frenkel LM
    AIDS Res Hum Retroviruses; 2000 Mar; 16(5):415-21. PubMed ID: 10772527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fluconazole on pharmacokinetics of 2',3'-dideoxyinosine in persons seropositive for human immunodeficiency virus.
    Bruzzese VL; Gillum JG; Israel DS; Johnson GL; Kaplowitz LG; Polk RE
    Antimicrob Agents Chemother; 1995 May; 39(5):1050-3. PubMed ID: 7625787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
    Kendall J; Papich MG
    Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.